During this study: classical symptoms for asthma: 88%, clinical symptoms correlating to step 4: 95%, obstructive and / or mixed syndromes: 26%, positive response to broncholators: 53%, FEV1: 77±18%, PEF: 78±23%, using ICS + LABA to treat asthma: 97%, good compliance with treatment: 95%.